BioMedNewsBreaks – MediXall Group Inc. (MDXL) Launches New Telehealth Solutions for Uninsured, Underinsured

MediXall Group (OTCQB: MDXL), a technology and innovation-driven organization focused on reducing costs of health care and transforming the patient-provider experience through the launch of its Health Karma(TM) platform, today announced new virtual-care solutions for the uninsured and underinsured. Effective immediately, Americans can conduct an online medical visit with a board-certified medical professional to get fast and easy treatment, prescriptions and lab tests for routine medical issues. This new service is a result of Health Karma’s recent partnership with leading telehealth company MeMD. “Telehealth will continue to be a popular option for patients, providers and employers beyond the pandemic,” Health Karma President Michael Swartz said in the news release. “It is a privilege for Health Karma to provide affordable virtual care for our users to ensure they get the care they need at a price that is accessible.”

Click here to view the full press release.

About MediXall Group Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for health care without intruding on the important relationship with trusted doctors. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective health care for the consumer. By approaching the health-care ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. For more information, visit www.MediXallGroup.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential

Disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE:…

2 days ago

BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ:…

6 days ago

BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Expands GelrinC Clinical and Commercial Pathways

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cell-free cartilage repair implant along parallel U.S. clinical…

6 days ago

BioMedNewsBreaks — Earth Science Tech Inc. (ETST) Marks Growth as Avenvi Expands Asset Base

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position…

6 days ago

BioMedNewsBreaks – NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Completes Three Large-Animal Procedures Using StereoCED(TM) Platform

NeuroOne (NASDAQ: NMTC) reported the successful completion of three large-animal procedures using its next-generation StereoCED(TM) platform as part of…

6 days ago

BioMedNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) to Report Second-Quarter 2026 Financial Results Sept. 9

Nanox (NASDAQ: NNOX), an innovative medical imaging technology company, announced it will report financial results…

1 week ago